3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDIV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Urinary Bladder Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Lung Neoplasms
1
Colorectal Neoplasms
1
Adenocarcinoma
1
Interventions
Tacrolimus
2
Pyridostigmine Bromide
2
Prednisone
2
sargramostim
1
pembrolizumab
1
Watchful Waiting
1
Steroids
1
Mycophenolic Acid
1
Methylprednisolone
1
Methotrexate
1
Ipilimumab
1
Immunosuppressive Agents
1
Immunoglobulins, Intravenous
1
Cyclosporine
1
Cyclophosphamide
1
Biological Products
1
Azathioprine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDIV
×
Observational
×
sargramostim
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled